Fintel reports that on March 12, 2025, LifeSci Capital initiated coverage of Monte Rosa Therapeutics (NasdaqGS:GLUE) with a ...

LifeSci Capital initiated coverage of Monte Rosa Therapeutics (GLUE) with an Outperform rating and $19 price target Optimize Your Investment ...

Lifesci Capital assumed coverage on shares of Monte Rosa Therapeutics (NASDAQ:GLUE – Get Free Report) in a research report issued to clients and investors on Wednesday, Marketbeat reports. The ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Immunome (IMNM – Research Report) and Monte Rosa ...

The lengthening list of pharma alliances focused on molecular glue degraders has another entry after Novartis signed a deal with Monte Rosa Therapeutics worth up to $2.2 billion. The partnership ...

After hours: March 14 at 4:23:31 PM EDT Loading Chart for GLUE ...

Graham Allen, the former chief executive officer of British outdoor clothing brand Henri-Lloyd, passed away on 8 March 2025, ...

The South America-focused miner declared a final dividend of 1.94 cents per share, amounting to at least $10 million for ...

Baseball season is officially in high gear in California, with teams now fully back into the swing of things and into their ...

Precious metals miner Hochschild Mining on Wednesday restored its dividend policy as the company announced its best financial ...

Hochschild Mining (HOC) has committed to handing shareholders at least $10mn (£7.7mn) a year in dividends as record gold prices drive up its earnings. The company pulled the payout two years ago as ...